Based on our preliminary findings, catalase measured in red and white blood cells, along with Paraoxonase 1 measured in plasma, emerged as the most promising candidates among enzymatic antioxidants to distinguish patients with active IBD from healthy controls. Here, CAT is linked to inflammatory bowel disease.